LEONORA BANTUGAN: Open Payments
NPI 1285393181 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 12 payments from 8 companies in 2025. Trend: 2023 $1,482 · 2024 $2,095 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Ascendis Pharma Endocrinology Inc | 1 | $28 |
| Aurinia Pharma U.S., Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
| Travere Therapeutics, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $16 |
Products named: LOKELMA, Kerendia, Fabhalta, Yorvipath, LUPKYNIS, Ozempic, KRYSTEXXA.
Industry payments across CA — which companies pay providers there.
